Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments

NCT00382395 is registered in ClinicalTrials.gov with SOLX, Inc. as lead sponsor.

NCT NCT00382395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00382395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Lead sponsor
SOLX, Inc.
Phase
Phase 3
Overall status
Suspended
Start date
November 30, 2005
Completion date
July 31, 2017
Enrollment
180 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, glaucoma, open angle